The "N"-factor in non-small cell lung cancer: staging system and institutional reports.
作者信息
Rena Ottavio
机构信息
Thoracic Surgery Unit, University of Eastern Piedmont, AOU Maggiore della Carità, Novara, Italy.
出版信息
J Thorac Dis. 2016 Nov;8(11):3049-3052. doi: 10.21037/jtd.2016.11.37.
Abstract
摘要
相似文献
1
The "N"-factor in non-small cell lung cancer: staging system and institutional reports.非小细胞肺癌中的“N”因素：分期系统与机构报告
J Thorac Dis. 2016 Nov;8(11):3049-3052. doi: 10.21037/jtd.2016.11.37.
2
TNM Staging of Non-Small Cell Lung Cancer: Comparison of PET/MR and PET/CT.非小细胞肺癌的 TNM 分期：PET/MR 与 PET/CT 的比较。
J Nucl Med. 2016 Jan;57(1):21-6. doi: 10.2967/jnumed.115.162040. Epub 2015 Oct 15.
3
Impact of the new lung cancer staging system for a predominantly advanced-disease patient population.新肺癌分期系统对以晚期疾病为主的患者人群的影响。
J Thorac Oncol. 2010 Mar;5(3):340-3. doi: 10.1097/JTO.0b013e3181c8137a.
4
Preoperative staging of non-small cell lung cancer: prospective comparison of PET/MR and PET/CT.非小细胞肺癌的术前分期：PET/MR 与 PET/CT 的前瞻性比较。
Eur Radiol. 2016 Nov;26(11):3850-3857. doi: 10.1007/s00330-016-4255-0. Epub 2016 Feb 16.
5
Towards More Structure: Comparing TNM Staging Completeness and Processing Time of Text-Based Reports versus Fully Segmented and Annotated PET/CT Data of Non-Small-Cell Lung Cancer.迈向更结构化：文本报告的 TNM 分期完整性与非小细胞肺癌全分割和注释 PET/CT 数据处理时间的比较。
Contrast Media Mol Imaging. 2018 Nov 1;2018:5693058. doi: 10.1155/2018/5693058. eCollection 2018.
6
Advances in positron emission tomography technology have increased the need for surgical staging in non-small cell lung cancer.正电子发射断层扫描技术的进步增加了非小细胞肺癌手术分期的需求。
J Thorac Cardiovasc Surg. 2007 Mar;133(3):746-52. doi: 10.1016/j.jtcvs.2006.10.043.
7
Prognostic factors in resected satellite-nodule T4 non-small cell lung cancer.切除卫星结节型T4非小细胞肺癌的预后因素
Ann Thorac Surg. 2007 Sep;84(3):934-8; discussion 939. doi: 10.1016/j.athoracsur.2007.04.097.
8
Optimal anatomic coverage for CT in staging lung cancer: lessons from PET-CT correlation.CT 分期肺癌的最佳解剖覆盖范围：来自 PET-CT 相关性的经验。
Lung Cancer. 2011 Jul;73(1):59-62. doi: 10.1016/j.lungcan.2010.10.021. Epub 2010 Nov 20.
9
Evaluation of TMN classification for lung carcinoma with ipsilateral intrapulmonary metastasis.对伴有同侧肺内转移的肺癌进行TMN分类的评估。
Ann Thorac Surg. 1999 Aug;68(2):326-30; discussion 331. doi: 10.1016/s0003-4975(99)00465-8.
10
Validation of the proposed International Association for the Study of Lung Cancer non-small cell lung cancer staging system revisions for advanced bronchioloalveolar carcinoma using data from the California Cancer Registry.利用加利福尼亚癌症登记处的数据对国际肺癌研究协会提出的晚期细支气管肺泡癌非小细胞肺癌分期系统修订版进行验证。
J Thorac Oncol. 2007 Dec;2(12):1078-85. doi: 10.1097/JTO.0b013e31815ba260.
引用本文的文献
1
Analysis of prognostic factors in pT1-2 N1 lung cancer patients in the light surgical results.根据手术结果分析 pT1-2N1 期肺癌患者的预后因素。
Updates Surg. 2023 Jun;75(4):1011-1017. doi: 10.1007/s13304-023-01473-z. Epub 2023 Feb 25.
本文引用的文献
1
Missed Intrapulmonary Lymph Node Metastasis and Survival After Resection of Non-Small Cell Lung Cancer.非小细胞肺癌切除术后肺内淋巴结转移漏诊与生存情况
Ann Thorac Surg. 2016 Aug;102(2):448-53. doi: 10.1016/j.athoracsur.2016.03.096. Epub 2016 Jun 3.
2
The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for the Revision of the N Descriptors in the Forthcoming 8th Edition of the TNM Classification for Lung Cancer.国际肺癌研究协会肺癌分期项目：对即将发布的第 8 版肺癌 TNM 分类中 N 描述符修订的建议。
J Thorac Oncol. 2015 Dec;10(12):1675-84. doi: 10.1097/JTO.0000000000000678.
3
Metastasis to subsegmental and segmental lymph nodes in patients resected for non-small cell lung cancer: prognostic impact.非小细胞肺癌患者切除术后亚段和段淋巴结转移：预后影响。
Ann Thorac Surg. 2014 Mar;97(3):987-92. doi: 10.1016/j.athoracsur.2013.11.051. Epub 2014 Jan 28.
4
A proposal for combination of total number and anatomical location of involved lymph nodes for nodal classification in non-small cell lung cancer.提出一种非小细胞肺癌淋巴结分类的方法，即结合淋巴结总数和受累淋巴结的解剖位置。
Chest. 2013 Jun;143(6):1618-1625. doi: 10.1378/chest.12-0750.
5
Incomplete intrapulmonary lymph node retrieval after routine pathologic examination of resected lung cancer.常规肺癌切除术后肺内淋巴结取样不完整。
J Clin Oncol. 2012 Aug 10;30(23):2823-8. doi: 10.1200/JCO.2011.39.2589. Epub 2012 Jul 9.
6
Number of lymph nodes and metastatic lymph node ratio are associated with survival in lung cancer.淋巴结数量和转移淋巴结比率与肺癌的生存有关。
Ann Thorac Surg. 2012 May;93(5):1614-9; discussion 1619-20. doi: 10.1016/j.athoracsur.2012.01.065. Epub 2012 Mar 20.
7
Prognostic implication of metastasis limited to segmental (level 13) and/or subsegmental (level 14) lymph nodes in patients with surgically resected nonsmall cell lung carcinoma and pathologic N1 lymph node status.手术切除的非小细胞肺癌患者中，病理性 N1 淋巴结状态下，转移仅限于节段性（水平 13）和/或亚节段性（水平 14）淋巴结的预后意义。
Cancer. 2012 Sep 15;118(18):4512-8. doi: 10.1002/cncr.27424. Epub 2012 Jan 26.
8
The number of lymph node metastases as a prognostic factor in patients with N1 non-small cell lung cancer.淋巴结转移数目作为 N1 期非小细胞肺癌患者的预后因素。
Chest. 2011 Aug;140(2):433-440. doi: 10.1378/chest.10-2885. Epub 2011 Feb 3.
9
Which is the better prognostic factor for resected non-small cell lung cancer: the number of metastatic lymph nodes or the currently used nodal stage classification?对于切除的非小细胞肺癌，哪个是更好的预后因素：转移淋巴结的数量还是目前使用的淋巴结分期分类？
J Thorac Oncol. 2011 Feb;6(2):310-8. doi: 10.1097/JTO.0b013e3181ff9b45.
10
The IASLC lung cancer staging project: a proposal for a new international lymph node map in the forthcoming seventh edition of the TNM classification for lung cancer.国际肺癌研究协会肺癌分期项目：关于在即将出版的第七版肺癌TNM分类中制定新的国际淋巴结图谱的提议。
J Thorac Oncol. 2009 May;4(5):568-77. doi: 10.1097/JTO.0b013e3181a0d82e.
Zotero 插件